Foghorn Therapeutics (FHTX) Asset Utilization Ratio (2020 - 2026)

Foghorn Therapeutics' Asset Utilization Ratio history runs 7 years deep, the most recent figure standing at 0.13 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio rose 55.06% year-over-year to 0.13 in Q1 2026; TTM through Mar 2026 was 0.13, a 55.06% increase from a year earlier, with the FY2025 full-year figure at 0.13, up 61.66% from the prior year.
• Asset Utilization Ratio declined to 0.13 in Q1 2026 per FHTX's latest filing, from 0.15 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.15 in Q4 2025 and bottomed at 0.01 in Q1 2022.
• The 5-year median for Asset Utilization Ratio is 0.09 (2025), against an average of 0.08.
• Across the five-year window, Asset Utilization Ratio surged 1126.68% in 2022 and plunged 33.04% in 2024, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.05 in 2022, then surged by 148.61% to 0.11 in 2023, then plunged by 33.04% to 0.08 in 2024, then jumped by 100.98% to 0.15 in 2025, then dropped by 12.42% to 0.13 in 2026.
• Per Business Quant, the three latest FHTX Asset Utilization Ratio figures stand at 0.13 (Q1 2026), 0.15 (Q4 2025), and 0.11 (Q3 2025).